FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to haemostatic agents, namely to local biodegradable haemostatic agents for stopping intracavitary bleeding. Haemostatic composition in the form of a paste containing chitosan formate and water.
EFFECT: providing the possibility of stopping the continuing intracavitary haemorrhage in severely wounded patients and a technique for restoring blood circulation in the patients with traumatic and non-traumatic circulatory arrest.
1 cl, 1 dwg, 9 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DELIVERY OF A HEMOSTATIC AGENT | 2022 |
|
RU2828316C2 |
| LOCAL HEMOSTATIC AGENT | 2013 |
|
RU2519220C1 |
| LOCAL HAEMOSTATIC ANTIBACTERIAL AGENT | 2021 |
|
RU2776015C1 |
| METHOD FOR THE PREVENTION OF ADHESIONS DURING ABDOMINAL OPERATIONS UNDER CONDITIONS OF PARENCHYMAL BLEEDING IN AN EXPERIMENT | 2020 |
|
RU2744540C1 |
| HEMOSTATIC AGENT | 2015 |
|
RU2602305C1 |
| METHOD FOR SIMULATING COMBINED RADIATION-MECHANICAL INJURY OF SEVERE DEGREE WITH LAPAROSCOPIC LIVER INJURY | 2024 |
|
RU2828152C1 |
| METHOD OF MODELING A COMBINED RADIATION AND MECHANICAL INJURY | 2023 |
|
RU2799704C1 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH SEVERE LIVER INJURIES | 2017 |
|
RU2674874C1 |
| METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
| HEMOSTATIC SPONGE | 2018 |
|
RU2681184C1 |
